glp 1 dementia study Can popular diabetes and weight-loss drugs slow vascular dementia? An analysis on the role
Description
Taking a GLP-1
Learn how stress and cortisol may affect gut health and GLP-1 signaling through SCFAs and Akkermansia
Radiolabeled glucagon-like peptide 1 (GLP- 1) analog scintigraphy is a new, high-sensitivity imaging method for detecting small insulinomas
Combining different weight loss medications can amplify results, but safety and efficacy depend on your individual metabolism
What the 2025 Expert Consensus Found Using a Delphi process with 58 experts from 17 countries, the panel reviewed available evidence and reached key agreements: 1
Ph 2 datathat showed weight loss of between 9.4% and 14.7% after 36 weeks on the drug compared to 2.3% for the placebo group and is currently in Ph 3
